Oramed to present data on oral insulin formulation for Type II diabetes at Annual Meeting in Bethesda
Links shared publicly online about this topic.
- 772total visits
Oramed to present data on oral insulin formulation for Type II diabetes at Annual Meeting in Bethesda
Oramed Pharmaceuticals Inc. a developer of oral drug delivery systems, announced today that its work entitled "Extended exposure to an oral insulin formulation yields decreased insulin secretion in Type II diabetes subjects," will be presented at the Tenth Annual Meeting of the Diabetes Technology Society, to be held in Bethesda, Maryland this November.
View full resource at news-medical.net
Tags: Diabetes, Insulin, Type 2 Diabetes, Drug, Pharma
Most Recently Shared on October 27, 2010 at 5:40 am By:
Oramed to present data on oral insulin formulation for Type II diabetes at Annual Meeting in Bethesda: Oramed Phar... http://bit.ly/aVJAQA
Advertisement
